QPPV.COM KNOWLEDGE ASSESSMENT

Drug-Induced Liver Injury (DILI): From Liver Test Abnormalities to Causality and Regulatory Safety Assessment

Test your understanding of the concepts covered by Drug-Induced Liver Injury (DILI): From Liver Test Abnormalities to Causality and Regulatory Safety Assessment.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement best reflects the inspection and governance expectation for a pharmacovigilance system handling potential DILI?

The organisation needs only to show that cases were entered into the safety database The organisation should demonstrate a controlled, medically defensible and traceable process from hepatic observation through conclusion and any resulting action Inspection focuses exclusively on whether ALT thresholds were calculated correctly Only confirmed causal cases need to be documented

Question 2 of 10 A trial participant meets commonly used screening thresholds for ALT and bilirubin, but has progressive liver metastases and worsening liver tests before treatment began. What is the most appropriate conclusion?

The case is automatically a drug-induced Hy's Law case The laboratory findings should be ignored because cancer patients cannot develop DILI The findings represent a potential Hy's Law case requiring review, but the alternative disease explanation may substantially weaken drug causality The case should be classified as cholestatic solely because bilirubin is elevated

Question 3 of 10 A patient develops liver-test abnormalities during combination therapy. Which attribution strategy is most defensible?

Attribute the event automatically to the most recently started medicine Attribute the event to the medicine with the strongest public reputation for hepatotoxicity Reconstruct the exposure timeline for every plausible medicine and consider interactions and relative biological plausibility Assign causality equally to all medicines without further review

Question 4 of 10 ALT is 10 times the ULN and ALP is 2 times the ULN at the relevant assessment point. What R-ratio classification follows the conventional approach?

Cholestatic Mixed Hepatocellular Unclassifiable because bilirubin is required to calculate the R-ratio

Question 5 of 10 A patient develops a marked ALT elevation during treatment, but bilirubin, INR and clinical status remain normal. Which interpretation is most appropriate?

The patient has hepatic failure because ALT directly measures liver function The result demonstrates drug causality if the ALT exceeds a predefined threshold The finding indicates hepatocellular injury but does not by itself establish hepatic dysfunction or drug causality The result is clinically irrelevant unless ALP is also elevated

Question 6 of 10 Which combination most directly indicates clinically important hepatic dysfunction rather than injury alone?

ALT elevation with normal bilirubin and INR ALP elevation without symptoms Jaundice with coagulopathy and possible encephalopathy Mild GGT elevation alone

Question 7 of 10 What is the appropriate role of eDISH in clinical development?

It replaces individual medical review of liver-test abnormalities It identifies every case that is definitively caused by the investigational medicine It helps visualise and identify participants with potentially concerning ALT and bilirubin combinations for structured review It is a post-marketing case-processing requirement under EU GVP

Question 8 of 10 What is the principal limitation of using the R-ratio in DILI assessment?

It is a formal causality score that cannot be interpreted clinically It describes biochemical pattern at a defined time point but does not establish causality and may change during the course It can only be used when bilirubin is normal It is intended to replace investigation of alternative causes

Question 9 of 10 Which statement best describes the evidentiary status of a pharmacovigilance safety signal involving DILI?

A signal proves that the medicine caused the reported liver injuries A signal is a hypothesis requiring validation, analysis and prioritisation A signal requires immediate product withdrawal in every case A signal is equivalent to a confirmed adverse reaction

Question 10 of 10 ALT is 6 times the ULN and ALP is 2 times the ULN. Which biochemical pattern is most consistent with the conventional R-ratio classification?

Hepatocellular Mixed Cholestatic The pattern cannot be assessed without GGT

Drug-Induced Liver Injury (DILI): From Liver Test Abnormalities to Causality and Regulatory Safety Assessment

Cookie Settings